Preskoči na sadržaj
Digitalni repozitorijum Stomatološkog fakulteta u Pančevu

Pun zapis

dc:titleParkinson's Spectrum Mechanisms in Pregnancy: Exploring Hypothetical Scenarios for MSA in the Era of ART
dc:creatorDalibor, Kovacevic
dc:creatorGordana, Velikic
dc:creatorMarić, Dušan
dc:creatorL. Dusica, Maric
dc:creatorPuletić, Miljan
dc:creatorLjiljana, Gvozdenovic
dc:creatorDanilo, Vojvodic
dc:creatorGordana, Supic
dc:subjectmultiple system atrophy
dc:subjectpregnancy
dc:subjectassisted reproduction
dc:subjectalpha-synuclein aggregation
dc:subjectneuroinflammation
dc:subjectfetal microchimerism
dc:subjectoxidative stress
dc:subjectestrogen and progesterone
dc:subjectdisease progression
dc:subjectmaternal and fetal outcomes
dc:descriptionMultiple System Atrophy (MSA) is a rare, rapidly progressive neurodegenerative disorder marked by autonomic dysfunction, parkinsonism, and cerebellar ataxia. While predominantly affecting individuals in their fifth or sixth decade, advancements in assisted reproductive technologies (ART) have created new clinical scenarios involving pregnancies in women within MSA's typical onset range. Given the scarcity of documented MSA pregnancies, this review leverages insights from related Parkinson's spectrum mechanisms to explore hypothetical scenarios for how pregnancy-induced physiological changes might influence MSA progression. Pregnancy-induced hormonal fluctuations, including elevated estrogen and progesterone levels, may modulate α-synuclein aggregation and neuroinflammatory pathways. Immune adaptations, such as fetal microchimerism and Th2-biased immune profiles, introduce additional complexities, particularly in donor embryo pregnancies involving complex microchimerism. Metabolic demands and oxidative stress further intersect with these mechanisms, potentially accelerating disease progression. We analyze existing literature and theoretical models, emphasizing the need for interdisciplinary research. Clinical implications are discussed to propose evidence-based strategies for optimizing maternal-fetal outcomes. This paper identifies critical knowledge gaps and proposes avenues for future investigation to optimize maternal-fetal outcomes in this unique and underexplored clinical intersection.
dc:publisherBasel : MPDI
dc:date2025
dc:typeinfo:eu-repo/semantics/article
dc:typeinfo:eu-repo/semantics/publishedVersion
dc:identifierhttps://stomatoloskifakultet.rs/nauka/publikacija/886
dc:identifierDOI 10.3390/ijms26073348
dc:identifierISSN 1422-0067
dc:sourceInternational Journal of Molecular Sciences 26(3348): 1-39
dc:languageen
dc:rightsinfo:eu-repo/semantics/closedAccess
dc:rightsSva prava zadržana